For more details on the changes to the portfolio, during April, please read the previous portfolio update.
- International Book: Our
Man added the Cambria Global Value ETF (GVAL) which seeks to invest in regions
with low CAPEs.
- Equity Book: Trying to take advantage of the recent
pull-back in Internet-related names, Our Man added PNQI (Powershares Internet
Portfolio), TWTR, VIPS, P and QIWI.
Performance Review
April saw the most volatile month in the portfolio’s history, which largely reflected the increased exposure to markets. The portfolio ended the month down -2.19%, putting the YTD at –2.7%.
The losses were broadly
spread across the portfolio, with the main drivers being the International book
(-32bps), the Currencies book (-42bps) and especially the Equity book
(-137bps). The losses in the Equity book were driven by
the exposure to THRX and the Internet stocks (listed above). Both were impacted by a continuation of March’s
move away from growth-orientated or higher risk names. THRX, a biotech stock, suffered from this
though the company continues to move to split itself into 2 (a royalty-driven
company from its existing therapies, and a biotech firm based on its product
pipeline) which will go ahead during May, and will likely see the 2 ‘new’ stocks
move very differently. The old adage
about catching knives costing fingers rang true in April, with the Internet
stocks hurting the portfolio, with 4 of the 5 posting negative returns during the
month (though all 5 were profitable until the final week of the month).
The International book’s
losses came entirely from its position in Greece (GREK), its largest exposure,
with small positive contributions from exposure to Spain (EWP) and Italy (EWI)
failing to significantly offset this loss.
There’s been no change to the book, though both Spain and Italy are a
little closer to being reduced in size (given the nature of their moves over
the last 12-18mos) than Greece. The Currencies
book suffered as the Dollar’s meandering continued, with the positions Short Yen
(YCS) and Short Euro (EUO) both hurting the fund. The Yen’s move was largely in the broad trading
range that it’s been bouncing around within.
While the Euro strengthened during the month it also exhibited signs of
forming a top, something that would be more likely if Draghi’s promise to “do
whatever it takes” (i.e. some QE-equivalent) proved to be more than empty words.
The rest of the books
were largely flat on the month, with limited contributions. The Absolute/Bonds Funds (+11bps) benefited
from the strength in Treasuries, the NCAV book (-5bps) saw its sole position
fall slightly before being closed out, and the China Thesis (-3bps) and Energy
Efficiency (-4bps) books both posted small losses. The Technical Book (+5bps) benefited from the
rising markets, though the weakness of the NASDAQ prevented it from keeping up
with the markets, and the Puts/Hedges books (-13bps) suffered as Brazil rallied
strongly.
Portfolio (as at 4/30 - all
delta and leverage adjusted, as appropriate)
25.4% - Equities (THRX, PNQI,
TTM, RDY, QIWI, VIPS, TWTR, P & DRWI)
21.7% - International/Country (GREK,
EWP, EWI & GVAL)
20.6% - Technical (DDM, SSO and
QLD)
5.9%
- Bond/Absolute Return Funds (DLTNX and HSTRX)
0.2% - Energy Efficiency (AXPW, and XIDE)
-3.1% - Hedges/Put Options (premium of 51bps in EWZ Jan-15 puts, and 19bps in EWJ Jan-15 puts)
1.4% - China-Related Thesis (CROC – Short Australian Dollar, more than offset by CAF – Long Chinese A-Shares)
0.2% - Energy Efficiency (AXPW, and XIDE)
-3.1% - Hedges/Put Options (premium of 51bps in EWZ Jan-15 puts, and 19bps in EWJ Jan-15 puts)
1.4% - China-Related Thesis (CROC – Short Australian Dollar, more than offset by CAF – Long Chinese A-Shares)
-51.0% - Currencies (EUO – Short
Euro, YCS – Short Japanese Yen)
7.4% - Cash
Disclaimer: For added
clarity, Our Man is invested in all of the securities mentioned. He also
holds some cash and a few other securities (of negligible value). You
should not buy any of these securities because Our Man has mentioned them, but
should do your own work and decide what’s best for you.